Due to loss of function (LoF), major tumor suppressor gene TP53 has so far not been therapeutically addressed in NSCLC but presence and absence of its protein p53 may sensitize to specific treatment strategies [18]. Here, TP53 is linked to non-small cell lung carcinoma.